Myosotis Investments B.V. is a privately held company established in 2024. 

We provide financial and business support to various life science enterprises, who preferably are active in the field of molecular diagnostics.

Guided by a commitment to a healthier world, Myosotis invests in innovations that drive meaningful, lasting improvements in healthcare and quality of life.